Sign inJoin waitlistJoin the waitlist

Lawrence Honig

Director · New York Presbyterian Hospital

Credentials: · · · · · ·

History

NYS Center of Excellence for Alzheimer’s Disease · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

New York Presbyterian Hospital
2022–2026
Pediatrics
Stanford University School of Medicine
1990–1993
Internal Medicine
Stanford University Medical Center in California
1987–1990
Stanford University School of Medicine
1986–1987
University of California at Berkeley in California
Univ of Miami Leonard M. Miller Sch of Med
1982–1986
Cornell University

Research

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
Review · Neurology · 2017 · 3,399 citations
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Systematic review or meta-analysis · Nature Genetics · 2019 · 2,420 citations
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
The Lancet Neurology · 2013 · 2,366 citations

Neill Graff-Radford
61 papers
Richard Mayeux
46 papers
Bradford Dickerson
38 papers
Douglas Galasko
37 papers
Mario Mendez
37 papers
CO
Chiadikaobi Onyike
36 papers
Liana Apostolova
36 papers
Gregory Day
35 papers
Ranjan Duara
35 papers
Joseph Masdeu
34 papers
Bradley Boeve
33 papers
Thomas Wingo
31 papers

Grants

Development of a Stress Kinase Inhibitor Therapeutic Candidate for Alzheimer's Disease and Related Dementia
National Institute on Aging · R44
PI · $2.9M · Neurokine Therapeutics, Llc
2020–2025
Targeting Lewy Body Specific Pathology Using Biomarkers
National Institute of Neurological Disorders and Stroke · U01
PI · $4.5M · Columbia University Health Sciences
2016–2024
Alzheimer's Disease Research Center - Overall
National Institute on Aging · P50
Project lead · $10.6M · Columbia University Health Sciences
1997–2021
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $21.9K · Columbia University Health Sciences
2005

Clinical trials

MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease
Principal investigator · Unknown · Phase 2
Neurokine Therapeutics
2022–2024
PrP-targeting siRNA Safety & Mechanism Study
Site PI · Recruiting · Phase 1
Broad Institute of MIT and Harvard
2026–2029
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Site PI · Recruiting
Mayo Clinic
2020–2030